VERTEX PHARMACEUTICALS INC / MA Cost of Revenue 2010-2025 | VRTX
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is VERTEX PHARMACEUTICALS INC / MA's current cost of revenue?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual cost of revenue for 2025 was $1.65B, a 7.89% increase from 2024. VERTEX PHARMACEUTICALS INC / MA cost of revenue for the quarter ending December 31, 2025 was $466.0M.
What was VERTEX PHARMACEUTICALS INC / MA's cost of revenue in 2024?
VERTEX PHARMACEUTICALS INC / MA annual cost of revenue for 2024 was $1.53B, a 21.26% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's cost of revenue in 2023?
VERTEX PHARMACEUTICALS INC / MA annual cost of revenue for 2023 was $1.26B, a 16.84% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year cost of revenue CAGR?
VERTEX PHARMACEUTICALS INC / MA cost of revenue grew at a compound annual growth rate (CAGR) of 17.53% from FY2020 to FY2025, going from $736.3M to $1.65B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.65B | +7.9% | 10-K |
| FY2024 | $1.53B | +21.3% | 10-K |
| FY2023 | $1.26B | +16.8% | 10-K |
| FY2022 | $1.08B | +19.5% | 10-K |
| FY2021 | $904.2M | +22.8% | 10-K |
| FY2020 | $736.3M | +34.4% | 10-K |
| FY2019 | $547.8M | +33.8% | 10-K |
| FY2018 | $409.5M | +48.9% | 10-K |
| FY2017 | $275.1M | +30.7% | 10-K |
| FY2016 | $210.5M | +79.6% | 10-K |
| FY2015 | $117.2M | +194.9% | 10-K |
| FY2014 | $39.7M | -55.4% | 10-K |
| FY2013 | $89.0M | -62.4% | 10-K |
| FY2012 | $236.7M | +272.1% | 10-K |
| FY2011 | $63.6M | - | 10-K |
| FY2010 | $0 | - | 10-K |